Madison Avenue Partners, LP - 31 Dec 2024 SCHEDULE 13G/A Report for Ovid Therapeutics Inc. Common Stock, par value $0.001 per share (the "Common Stock") (OVID)

Filing manager
Madison Avenue Partners, LP
Reporting owner
Madison Avenue Partners, LP
Security
Ovid Therapeutics Inc. Common Stock, par value $0.001 per share (the "Common Stock")
Beneficially owned shares
2,852,352 shares
Ownership signal CIK-linked ownership evidence from parsed SEC filings. 2 signals
Large-stake signal

Form

SCHEDULE 13G/A

Passive or exempt beneficial ownership filing.

Ownership

4%

Beneficial ownership of this reported class.

Shares

2,852,352 shares

Shares beneficially owned as disclosed.

Event date

31 Dec 2024

Date tied to the ownership event or amendment.

Accepted by SEC

14 Feb 2025

EDGAR acceptance date.

How to read this large-stake filing
  • Schedule 13D/G filings focus on beneficial ownership stakes, not a full portfolio.
  • Compare this filing with the holder history and issuer page before treating the percentage as a current position.
  • Use amendments to understand whether the disclosed stake increased, decreased, or changed reporting status.
Class ownership
4%
Subject security Names, identifiers, and filing context for this profile. 2 source fields
Symbol
OVID
Shares outstanding
71,308,800 shares
Source evidence Original filing metadata and source links for verification. 4 source fields
SEC form
SCHEDULE 13G/A
Accepted by SEC
14 Feb 2025, 17:41:31 UTC
Event date
31 Dec 2024
Source filing
View source filing

Key filing fact

Madison Avenue Partners, LP disclosed 4% ownership in Ovid Therapeutics Inc. Common Stock, par value $0.001 per share (the "Common Stock") (OVID) on 31 Dec 2024.

Key facts

  • Madison Avenue Partners, LP filed SCHEDULE 13G/A for Ovid Therapeutics Inc. Common Stock, par value $0.001 per share (the "Common Stock") (OVID).
  • Disclosed ownership: 4%.
  • Date of event: 31 Dec 2024.

Change

  • No earlier schedule filing is available for direct comparison.
  • Current filing was accepted on 14 Feb 2025, 17:41.

Research use

  • This page turns one Schedule 13D/G filing into a quick large-stake read before the raw reporting-person rows.
  • Use the linked SEC filing as the source of truth for ownership percentages, shares, and reporting-party details.

Evidence

Backed by Schedule 13D/13G

Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.

View source filing

Reporting persons

Disclosed reporting parties (6)

Names, ownership percentages, voting power, signatures, titles, and CIKs as disclosed in this Schedule 13D/G filing.

Name Ownership Shares owned Sole voting power Shared voting power Signature Title CIK
Madison Avenue Partners, LP 4% 2,852,352 0 2,852,352 /s/ Eli Samaha Eli Samaha, as Managing Member of EMAI Management, LLC the General Partner of Madison Avenue Partners, LP
Madison Avenue International LP 4% 2,852,352 0 2,852,352 /s/ Eli Samaha Eli Samaha, as Manager of Madison Avenue GP, LLC, the General Partner of Madison Avenue International LP
EMAI Management, LLC 4% 2,852,352 0 2,852,352 /s/ Eli Samaha Eli Samaha, as Managing Member
Madison Avenue GP, LLC 4% 2,852,352 0 2,852,352 /s/ Eli Samaha Eli Samaha, as Manager
Caraway Jackson Investments LLC 4% 2,852,352 0 2,852,352 /s/ Eli Samaha Eli Samaha, as Member
Eli Samaha 4% 2,852,352 0 2,852,352 /s/ Eli Samaha Eli Samaha
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .